Healthcare
About
Medea provides products vital to confronting national healthcare challenges. The Company is a distributor of the highest quality FDA-approved pharmaceuticals, immunoassay and molecular diagnostic products made in the United States.
Medea is currently aiding in the fight against the opioid crisis. As an authorized distributor of Hikma USA, Medea offers the life-saving opioid reversal agent, “Kloxxado.”
Throughout the challenges of the Covid-19 pandemic, Medea assisted in the distribution of crucial health and safety products. The Company delivered more than 25 million face masks and N95 respirators to the Federal Emergency Management Agency (FEMA). Medea also supplied millions of units of PPE to hospitals and the private sector, including Lowe’s, Walmart, AEG and others in the United States and Canada.
During the height of the pandemic, the development of the Covid-19 rapid antigen test was a breakthrough on the road back to “normal.” Responding to the needs of the US Army, the Department of Defense awarded a $190 million contract to Medea for diagnostic tests for non-prescription home use.
Operating within CDC and state and local government guidelines, Medea was chosen as the testing company of choice by notable venues such as the Staples Center, The Forum, Pechanga Arena, Los Angeles Convention Center, Dignity Health Sports Park, Toyota Sports Performance Center, Enterprise Center, the Stifel Theatre, Toyota Arena, the University of San Diego, and Dolby Theatre, among others.
From the delivery of PPE and rapid antigen tests during the height of the Covid-19 crisis, to the distribution of opioid countermeasures, to much-needed baby formula, Medea has the expertise and infrastructure to deliver products necessary to combat the crises of our time. Medea is an authorized distributor of Hikma USA, Quidel Diagnostics and Acon Laboratories. Medea’s mission is to continue to distribute trusted products across the United States.